Ophthalmic Drugs Market, By Drug Class (Anti-glaucoma Drug, Dry eye Drug, Ophthalmic Anti-allergy/Inflammatory, Retinal Drug, Anti-infective Drugs, and Other Drugs), By Product Type (OTC Drug, Prescription Drug), By Region (North America, Europe, Asia Pacific, Middle East & Africa, and South America) – Market Size & Forecast 2032

The Ophthalmic Drugs Market report includes a global opportunity analysis and industry forecasts for the period 2023-2032. The global market is valued at USD $32.98 billion in 2022 and is expected to register a CAGR of 6.45% from 2023 to 2032. The base year considered for the study is 2022 and the forecast has been provided for the period 2023 to 2032.

The Ophthalmic Drugs Market report points out national and global business prospects and competitive conditions for ophthalmic drugs. Market size estimation and forecasts were given based on a detailed research methodology tailored to the conditions of the demand for ophthalmic drugs. The ophthalmic drugs market has been segmented by drug class (anti-glaucoma drug, dry eye drug, ophthalmic anti-allergy/inflammatory, retinal drug, anti-infective drugs, and other drugs), by product type (otc drug, prescription drug). Historical background for the demand of ophthalmic drugs has been studied according to organic and inorganic innovations in order to provide accurate estimates of the market size. Primary factors influencing the growth of the demand ophthalmic drugs have also been established with potential gravity. Major regions covered in the study include North America, Europe, Asia Pacific, Middle East & Africa, and South America.

Ophthalmic Drugs Market

Figure 1: Ophthalmic Drugs Market

Market Segmentation:

By Drug Class:   

  • Anti-glaucoma Drug
  • Dry eye Drug
  • Ophthalmic Anti-allergy/Inflammatory
  • Retinal Drug
  • Anti-infective Drugs
  • Other Drugs

By Product Type:

  • OTC Drug
  • Prescription Drug

By Region:

North America Ophthalmic Drugs Market

  • North America, by Country
    • US
    • Canada
    • Mexico
  • North America, by Drug Class
  • North America, by Product Type

Europe Ophthalmic Drugs Market

  • Europe, by Country
    • Germany
    • Russia
    • UK
    • France
    • Italy
    • Spain
    • The Netherlands
    • Rest of Europe 
  • Europe, by Drug Class
  • Europe, by Product Type

Asia Pacific Ophthalmic Drugs Market

  • Asia Pacific, by Country
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Indonesia
    • Rest of Asia Pacific 
  • Asia Pacific, by Drug Class
  • Asia Pacific, by Product Type

Middle East & Africa Ophthalmic Drugs Market

  • Middle East & Africa, by Country 
    • UAE
    • Saudi Arabia
    • Qatar
    • South Africa
    • Rest of Middle East & Africa
  • Middle East & Africa, by Drug Class
  • Middle East & Africa, by Product Type

South America Ophthalmic Drugs Market

  • South America, by Country 
    • Brazil
    • Argentina
    • Colombia
    • Rest of South America
  • South America, by Drug Class
  • South America, by Product Type

Major Companies: Aerie Pharmaceuticals Inc., Allergan, Bausch Health, Bayer AG, F. Hoffmann-La Roche Ltd, Hoya Corporation, Novartis AG, Pfizer Inc., and Regeneron Pharmaceuticals Inc.

Years Covered in the Study:

Historic Year: 2021

Base Year: 2022

Estimated Year: 2023

Forecast Year: 2032

Objectives of this report:

  • To estimate market size for ophthalmic drugs market on regional and global basis.
  • To identify major segments in ophthalmic drugs market and evaluate their market shares and demand.
  • To provide a competitive scenario for the ophthalmic drugs market with major developments observed by key companies in the historic years.
  • To evaluate key factors governing the dynamics of ophthalmic drugs market with their potential gravity during the forecast period.

Reasons to Buy This Report:

  • Provides niche insights for decision about every possible segment helping in strategic decision making process.
  • Market size estimation of the ophthalmic drugs market on a regional and global basis.
  • A unique research design for market size estimation and forecast.
  • Identification of major companies operating in the market with related developments
  • Exhaustive scope to cover all the possible segments helping every stakeholder in the ophthalmic drugs

Customization:

This study is customized to meet your specific requirements:

  • By Segment
  • By Sub-segment
  • By Region/Country
  • Product Specific Competitive Analysis

For more information, contact: sales@quincemarketinsights.com